We worked with the incredibly talented scientists at Pulmocide, to translate the evidence and data behind their unique approach to inhaled anti-infectives into something visual.
Pulmocide have overcome the technical challenges of creating targeted and long-lasting, inhaled anti-infective medicines. They have done this through a deep understanding of the properties of lung epithelium, and a desire to improve quality of life in vulnerable patients who experience the unpleasant side effects of current systemic treatments.
First, we worked closely with the company’s management team to understand the heritage and unique positioning of Pulmocide’s offering, and developed a more appropriate brand platform and visual identity to help us tell their scientific story. Then, by understanding the technical details of Pulmocide’s drug development platform and using data from their pre-clinical studies, we were able to structure infographics and website content that explains who Pulmocide are, why their approach to inhaled medicines is beneficial, and the clinical impact that these medicines could have.
Explore the site to find out more www.pulmocide.com